Proteases-From Basic Structure to Function to Drug Design as Targeted Therapy

In the two last decades, proteases have constituted one of the primary and important targets in drug discovery. The U.S. FDA has approved more than 12 protease therapies in the last 10 years, and a number of next-generation or completely new proteases are under clinical development. Protease inhibit...

Full description

Saved in:
Bibliographic Details
Other Authors: Kwok, Hang Fai (Editor), Shaw, Christopher (Editor), Walker, Brian (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_77096
005 20220111
003 oapen
006 m o d
007 cr|mn|---annan
008 20220111s2021 xx |||||o ||| 0|eng d
020 |a books978-3-0365-2574-7 
020 |a 9783036525754 
020 |a 9783036525747 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-2574-7  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
100 1 |a Kwok, Hang Fai  |4 edt 
700 1 |a Shaw, Christopher  |4 edt 
700 1 |a Walker, Brian  |4 edt 
700 1 |a Kwok, Hang Fai  |4 oth 
700 1 |a Shaw, Christopher  |4 oth 
700 1 |a Walker, Brian  |4 oth 
245 1 0 |a Proteases-From Basic Structure to Function to Drug Design as Targeted Therapy 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (93 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a In the two last decades, proteases have constituted one of the primary and important targets in drug discovery. The U.S. FDA has approved more than 12 protease therapies in the last 10 years, and a number of next-generation or completely new proteases are under clinical development. Protease inhibition strategies are one of the fastest expanding areas in the field of of drugs that show considerable promise. This Special Issue will focus on the recent advances in the discovery and development of protease inhibitors, covering the synthesis of protease inhibitors, the design of new chemical entities acting as inhibitors of special/particular types of proteases, and their mode of actions (Frolova et al. 2020; Slapak et al. 2020; Künnapuu et al. 2021). In addition, the new applications of these interesting compounds/biomolecules and their limitations have been discussed and described (Wang et al. 2020; Bartošová-Sojková et al. 2021). 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
653 |a MMP 
653 |a MMP2 
653 |a MMP9 
653 |a MMP7 
653 |a MMP14 
653 |a matrix metalloproteases 
653 |a PDAC 
653 |a pancreatic cancer 
653 |a Bowman-Birk inhibitor 
653 |a ranacyclin 
653 |a trypsin inhibitor 
653 |a structure-activity relationship 
653 |a synergistic effect 
653 |a Gentamicin 
653 |a matrix metalloproteinase 
653 |a extracellular matrix 
653 |a nuclei 
653 |a cancer 
653 |a apoptosis 
653 |a immune response 
653 |a cysteine protease inhibitor 
653 |a stefin 
653 |a signal peptide 
653 |a parasite 
653 |a phylogenetic analysis 
653 |a diversification 
653 |a protein structure 
653 |a vascular endothelial growth factors (VEGFs) 
653 |a VEGF-A 
653 |a PlGF 
653 |a VEGF-B 
653 |a VEGF-C 
653 |a VEGF-D 
653 |a angiogenesis 
653 |a lymphangiogenesis 
653 |a CCBE1 
653 |a proteases 
653 |a ADAMTS3 
653 |a plasmin 
653 |a cathepsin D 
653 |a KLK3 
653 |a prostate-specific antigen (PSA) 
653 |a thrombin 
653 |a wound healing 
653 |a metastasis 
653 |a proteolytic activation 
653 |a vascular biology 
653 |a lymphedema 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/4715  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/77096  |7 0  |z DOAB: description of the publication